Neuropsychopharmacology
- Is abnormal brain insulin action implicated in the biology of depression? A pilot neuroimaging study in adolescents2 weeks ago
- Neuronal genetic risk within the multicellular landscape of schizophrenia3 weeks ago
- Psychedelics produce enduring enhancement of reward responsiveness in male rats3 weeks ago
- The neuroanatomy of depression: weak but replicable effects in 4021 individuals from three clinical cohorts3 weeks ago
- Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study3 weeks ago
- Correction: Cue labeling reduces cigarette craving and associated neural activity3 weeks ago
- In memoriam – Ming T. Tsuang, M.D., Ph.D., D.Sc3 weeks ago
Journal of Psychopharmacology
- Effects of pimavanserin, xanomeline and highly-purified plant-derived cannabidiol on MK-801-induced behaviours in mice relevant to psychosis1 month ago
- The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential1 month ago
- Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants1 month ago
- Angiotensin II and angiotensin-(1–7) neurotransmissions in the medial amygdala differently control cardiovascular and anxiogenic-like responses to stress in rats1 month ago
- A noninvasive approach to modeling cocaine self-administration in mice1 month ago
- Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review1 month ago
- Enhanced cognitive protection through the combination of Amylovis-201, an anti-amyloidogenic agent with sigma-1 receptor agonist activity, and environmental enrichment in mice1 month ago
European Neuropsychopharmacology
- Recommendations of the ECNP Digital Network for the evaluation of mental health care apps: A Delphi consensus2 months ago
- Dot the i’s and cross the t’s: Can we get resilience in bipolar disorder right, please?2 months ago
- Reconsidering regression-based predictors in adults with attention‑deficit/hyperactivity disorder and substance use disorders2 months ago
- Prevalence and outcomes of co-occurring psychiatric and endocrine, metabolic, and nutritional disorders: An atlas based on umbrella review of 254,154,533 records2 months ago
- Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers2 months ago
- From association to screening: calibrating neurological risk in severe mental illness2 months ago
- Rethinking neurocognitive and cardiometabolic screening in severe mental illness2 months ago